JUN 13, 2018 05:42 AM PDT

Psychedelics May Serve as Potential Treatment for Depression

WRITTEN BY: Nouran Amin

Research at the University of California is examining the effect of hallucinogenic drugs on the brain and how this research can potentially provide some answers in treating depression and other mental disorders. The latest findings have shown the ability of these psychedelic drugs to change the neurons and glial cells present in the brains of rat and flies; primarily increasing the connectivity between neuronal cells.

Although depression has long been believed to be asocated with chemical imbalances in the brain, recent research has provided evidence of how structural changes in parts of the brain can also be associated with depression. For example, in a recent fMRI study, the hippocampus was found to be around 9 to 13 percent smaller among individuals afflicted with depression.

Senior author David E. Olson discussed that “one of the hallmarks” of depression is the presence of shriveled up neurites in the prefrontal cortex of the brain. The prefrontal cortex is the region of the brain concerned with emotion and mood regulation. “People have long assumed that psychedelics are capable of altering neuronal structure, but this is the first study that clearly and unambiguously supports that hypothesis,” he said. “What is really exciting is that psychedelics seem to mirror the effects produced by ketamine.”

Despite multiple limitations, Ketamine was studied to have antidepressant properties. Olson and co-researchers were particularly interested in how psychedelics could hold the similar effects of ketamine on neurons grown in a petri dish. But after treatment with a dose of DMT (a psychedelic compound), rats had an increase in the number of dendritic spines, which was similar when these rat model were treated with ketamine.

"These are some of the most powerful compounds known to affect brain function, it's very obvious to me that we should understand how they work," said Olson. With these research findings, it was crucial to bring the risks of psychedelics into light. For one, the drugs could induce forms of psychotic disorders particularly in individuals who are genetically predisposed.

The researchers tested psychedelics from the amphetamine, tryptamine, and ergoline drug classes. Talaverabeads/Pixabay, Image via MedicalDaily.com

A professor of clinical psychiatry, by the name of Richard A. Friedman, at the Weill Cornell Medical College, believes that psychedelics may be behaviorally toxic, as well as an addictive similar to cocaine or alcohol. “Psychedelics might turn out to have real promise, but that needs to be proven through large, rigorous, placebo-controlled trials. We’re not there yet,” he cautioned.

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
APR 24, 2018
Drug Discovery
APR 24, 2018
Discovery of a Protein led to a Therapeutic Approach For Asthma
Asthma is a chronic respiratory disease. It is common and affects more than 300 million people worldwide and over 40 million people in the United States. I...
APR 24, 2018
Drug Discovery
APR 24, 2018
New Treatment Option for the Non-Cancerous Form of the Prostate
A new therapy known as ‘prostate artery embolization’ or PAE seeks to treat the non-cancerous enlargement of the prostate, or benign prostatic...
MAY 03, 2018
Drug Discovery
MAY 03, 2018
Re-Designing Treatments for Alzheimer Disease
The most common form of dementia is Alzheimer which is a general term for memory loss and other cognitive abilities that complicate activities of daily lif...
MAY 03, 2018
Drug Discovery
MAY 03, 2018
Treating Migraines with Less Side-Effects
According to a 2013 Global Burden of Disease Study and the World Health Organization (WHO), migraine makes the list as the sixth highest cause worldwide fo...
JUN 06, 2018
Drug Discovery
JUN 06, 2018
Metformin Safe for Diabetics with CKD
An oral diabetes drug, by the name of metformin, is suggested to be safe for most diabetic individuals with chronic kidney disease (CKD) according to a rec...
JUN 12, 2018
Drug Discovery
JUN 12, 2018
An Acetylcholine Blocker May Prevent Drug Addiction Relapse
It may sound like a paradox to produce a drug that is used to treat a drug addiction but scitnfcially speaking this is a logical possibility according to s...
Loading Comments...